RIDGEWOOD DIAGNOSTIC LABORATORY LLC NPI 1568839173

NPI Details

RIDGEWOOD DIAGNOSTIC LABORATORY, LLC is a clinical medical laboratory in Hackensack, NJ. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. RIDGEWOOD DIAGNOSTIC LABORATORY, LLC NPI is 1568839173. The provider is registered as an organization entity type.

The provider's business location address is:

126 STATE STREET
2ND FLOOR
HACKENSACK, NJ
ZIP 07601
Phone: (973) 542-2343
Fax: (201) 632-6548

The provider's authorized official is Alexandr Zaitsev .
The authorized official title is President and has the following contact phone number (862) 703-0506.

The CLIA number assigned to this NPI record is 31D2109691 - independent with a certificate type of Certificate of Compliance.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0004)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source (HCPCS:G2023)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0483)
• Testing for presence of drug, by chemistry analyzers (HCPCS:80307)
• Test for detecting genes associated with disease, genomic sequence, must include sequence analysis of entire mitochondrial genome (HCPCS:81460)
• Test for detecting genes associated with disease, whole mitochondrial genome (HCPCS:81465)
• Gene analysis (postmeiotic segregation increased 2 [s cerevisiae]) full sequence analysis (HCPCS:81317)
• Gene analysis (muts homolog 6 [e coli]) full sequence analysis (HCPCS:81298)
• Gene analysis (glucose-6-phosphate dehydrogenase) full sequence analysis (HCPCS:81249)
• Gene analysis (muts homolog 6 [e coli]) duplication or deletion variants (HCPCS:81300)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• Gene analysis (cystic fibrosis transmembrane conductance regular) full gene sequence (HCPCS:81223)
• Gene analysis (glucosidase, beta, acid) common variants (HCPCS:81251)
• Gene analysis (methyl cpg binding protein 2) full sequence analysis (HCPCS:81302)
• Gene analysis (cystic fibrosis transmembrane conductance regular) duplication or deletion variants (HCPCS:81222)
• Gene analysis (fragile x mental retardation) abnormal alleles (HCPCS:81243)
• Gene analysis (calcium voltage-gated channel subunit alpha1 a) for abnormal alleles (HCPCS:81184)
• Gene analysis (methyl cpg binding protein 2) duplication or deletion variants (HCPCS:81304)
• Molecular pathology procedure level 1 (HCPCS:81400)
• Test for detecting genes associated with colon cancer, promoter methylation analysis (HCPCS:81288)
• Gene analysis (peripheral myelin protein 22), full sequence analysis (HCPCS:81325)
• Gene analysis (muts homolog 2, colon cancer, nonpolyposis type 1) full sequence analysis (HCPCS:81295)
• Gene analysis (mpl proto-oncogene, thrombopoietin receptor) sequence analysis of exon 10 (HCPCS:81339)
• Gene analysis (janus kinase 2) targeted sequence analysis (HCPCS:81279)
• Gene analysis (adenomatous polyposis coli), full gene sequence (HCPCS:81201)
• Gene analysis (adenomatous polyposis coli), duplication or deletion variants (HCPCS:81203)
• Gene analysis (bloom syndrome, recq helicase-like) (HCPCS:81209)
• Gene analysis (coagulation factor ix) full sequence analysis (HCPCS:81238)
• Gene analysis (fanconi anemia, complementation group c) common variant (HCPCS:81242)
• Gene analysis (glucose-6-phosphatase, catalytic subunit) common variants (HCPCS:81250)
• Gene analysis (partner and localizer of brca2) full sequence analysis (HCPCS:81307)

The enumeration date for this NPI number is 8/31/2015 and was last updated on 11/20/2018.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: